Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone
- 31 October 1987
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 23 (11), 1659-1664
- https://doi.org/10.1016/0277-5379(87)90446-9
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- 8 Chemotherapy and radiotherapy of malignant hepatic tumoursBailliere's Clinical Gastroenterology, 1987
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levelsJournal of Hepatology, 1986
- Active uptake of testosterone by androgen receptors of hepatocellular carcinoma in humansCancer, 1986
- Androgen and estrogen receptors in hepatocellular carcinoma and in the surrounding noncancerous liver tissueHepatology, 1986
- Mitozantrone as single agent therapy in hepatocellular carcinoma: A phase II studyJournal of Hepatology, 1985
- Characterisation of high affinity binding sites of androgens in primary hepatocellular carcinomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Androgen receptors in hepatocellular carcinoma and surrounding parenchymaGastroenterology, 1985
- Primary liver cancer. An eastern cooperative oncology group trialCancer, 1984
- Sex steroid receptor proteins in foetal, adult and malignant human liver tissueBritish Journal of Cancer, 1983
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978